Sunteți pe pagina 1din 21

SURKESNAS 2001

National Household Health Survey


Morbidity Study

NCD RISK FACTORS IN INDONESIA

By

S. Soemantri
Julianty Pradono
Dwi Hapsari
Introduction

The World Health Organization (WHO) is pursuing surveillance as part of a


global strategy for preventing and controlling NCDs and the major risk factors that
predict them. The WHOs STEPwise approach to surveillance for NCD risk factors is
based on standardized data collection and a methodology that can be adapted to a variety
of country settings. The STEPwise approach encourages the development of an
increasingly comprehensive surveillance system that meets local needs. Moreover, for
sustainable surveillance, the STEPwise approach emphasizes small amounts of good
quality data over large amounts of poor quality data.

Indonesia Health Survey known as Survei Kesehatan Nasional (Surkesnas) is an


attempt to integrate all national-scope health surveys (National Household Health Survey
(NHHS), National Socio-Economic Survey (NSES) and Indonesia Demographic Health
Survey (IDHS)). The integration focuses on the use of common sampling design, format
of instruments, collaboration on survey preparation, training, field operation and data
utilization. The spirit of survey integration would not only lead towards cost effective
data collection but also avoid redundancy and extend the data availability. Surkesnas can
be considered as an approach of integrating various existing data collection system to
provide sustainable and optimal information for evidence (survey) based programming.
Sustainability of the surveys inspire the possibility rearranging system into surveillance
system.

SURKESNAS 2001 was integrated surveys of NHHS 2001 (mortality study,


morbidity study, MCH study and pregnant women follow up study), NSES 2001 (health
module) and IDHS 2002 (MCH module). NHHS 2001 has incorporated STEPS approach
within one of its component study: Morbidity Study.

Scope of STEPS within Morbidity Study

One component of NHHS 2001 is Morbidity Survey which Steps was


incorporated within the study instrument. Scope of Steps within this study includes Step
one, questions on smoking, alcohol consumption and physical activity. First version of
Step one questionnaire was adapted with some modification (see attachment 1). Step two
includes measurement on height, weight, waist, hip and blood pressure. Microtoise was
used to measure body height, digital uniscale to measure body weight, and mercury
sphygmomanometer to measure blood pressure. Steps three includes measurement of
blood glucose and total cholesterol (for specific area only: Java and Bali) and Accutrend
GC (dry chemistry) was used to collect blood glucose and total cholesterol.
Data collection of morbidity survey was executed by 78 field teams of NHHS
2001, each team consists of 2 medical doctors (male, female), one midwife, one
laboratory technician and one field coordinator (supervisor).

NHHS 2001 sampling design.

Sampling scheme of NSES 2001 was used for NHHS 2001. NSES 2001
employed principle of multi stages sampling design. For urban areas, census blocks
(CBs) were selected systematically, and 16 households were drawn in each selected CB
also systematically. For rural areas firstly sub-districts were selected with PPS, secondly
two CBs selected randomly in each selected sub-district and finally 16 households were
drawn systematically in each selected CB. NSES 2001 has sample size of 220,896 HH
(13,806 CB) for Core and 65,280 HH (4,080 CB) for Module. Core sample of NSES
2001 was also used for the sample of Mortality Study of NHHS 2001. Forty percent of
module sample of NSES 2001 was allocated for sample of NHHS 2001: MCH and
Pregnant women FU Studies, and 25% of HHs within this sample was allocated for
NHHS 2001: Morbidity Survey.

Morbidity survey was able to cover 98% of sampled census blocks, but only 84%
of households within the covered census blocks could be visited and 97% of household
members of those visited households were successfully interviewed/examined.

Findings

Total sample of 13,131 persons aged 15 years + for Indonesia was analysed
descriptively for NCD risk factors (Step 1 and Step 2), and only 4,081 persons aged 25
years + in Java-Bali included for blood glucose and total cholesterol descriptive analysis
(steps 3). Table 1 shows distribution of sampled persons aged 15 years+ by age group
and gender for Indonesia, and Table 2 shows distribution of sampled persons aged 25
years+ by age group and gender for Java and Bali. Sampling design of NSES provides
weight for each household selected in the sample, and this weight was used to calculate
the sample distribution (weighted n).

Table 3 shows prevalence rates of various NCD risk factors by age group, gender
and residence. 31% of sampled population aged 25 years + are current daily smoker.
Current daily smoker increases by age group except for the oldest. Smoking is more
prevalent for male and in rural. Alcohol consumption was reported very low only 3%,
more prevalent for male and in rural. Physical inactivity is very high (63%), more
prevalent in urban area than in rural area, and more prevalent for female than male. High
blood pressure was reported for 28% sampled population, increasing by age group, more
prevalent in urban and for female. Indication of obesity (21%) is shown by prevalence
rates of persons with WHR >1 for male and >0.85 for female, which is more prevalent
for women and for those live in urban. Similar pattern is also shown by percentage of
BMI 25kg/m2,16% of persons aged 25 years+ have BMI 25 kg/m2. Prevalence of
hyperglycemia (capillary blood glucose 110mg%) is 8% and prevalence of those with
total cholesterol above 200mg% is 7%.

Mean and prevalence rates for each risk factor by age group and gender are shown
in Tables 4-14.

Table 1
Weighted n (sample) distribution of persons aged 15 years+ by age and gender.
Morbidity Study (NHHS) 2001

Male Female Both sexes


Age (years) Weighted n Weighted n Weighted n
15-24 1444 1658 3102
25-34 1326 1728 3054
35-44 1266 1471 2737
45-54 943 1002 1945
55-64 645 629 1274
65+ 506 515 1021
Total 6130 7003 13133

Table 2.
Weighted n (sample) distribution of persons aged 25 years+ by age and gender
in Java-Bali, Morbidity Study (NHHS) 2001

Male Female Both sexes


Age (years)
Weighted n Weighted n Weighted n
25 34 572 739 1311
35 44 522 597 1119
45 54 372 417 789
55 64 252 244 496
65 + 177 189 366
Total 1895 2186 4081
Table 3
Prevalence of NCD risk factors for persons aged 25 years and above by
age group, gender, and residence, Morbidity Study (NHHS) 2001

Current Current Tension WHR risk BMI Capillary Total Weight


Characteristic daily alcohol In- 140/90 (M>1.0; 25 blood choles- ed n
smokers drink active mmHg F>0.85) kg/m2 glucose terol
110 mg% >200mg%
Age group(yr)
25-34 27.7 3.3 64.6 10.8 17.2 13.2 5.0 3.6 3,054
35-44 31.8 3.8 60.6 22.2 19.6 21.3 7.3 7.7 2,737
45-54 33.7 2.7 60.6 35.0 23.4 20.8 9.5 8.7 1,945
55-64 37.3 2.5 61.5 47.4 23.3 12.9 10.7 10.6 1,274
65+ 30.2 2.5 73.0 55.3 27.0 6.9 9.7 6.2 1,021
Sex
Male 63.5 5.8 56.7 26.5 2.1 10.2 8.9 5.8 4,686
Female 3.3 0.8 68.9 28.9 37.4 21.4 6.9 7.9 5,345

Residence
Urban 29.7 2.4 74.7 29.9 22.5 22.8 8.9 8.9 4,082
Rural 32.7 3.7 55.3 26.4 19.8 11.7 6.9 5.2 5,949

Total 31.4 3.2 63.2 27.8 20.9 16.2 7.8 6.9 10,031

Tables 4a and 4b show prevalence of tobacco use by age group for male and
female. Prevalence for male is much higher than for female. For male 78% is ever
smokers, 58% is current daily smokers and the figures for female are 6% and 3%
respectively. Both male and female current daily smokers have similar median age at start
of daily smoking i.e. 19 years old.

Table 4a
Prevalence of tobacco use for male by age group,
Morbidity Study (NHHS) 2001

Age Ever Current Ex-daily Median age at


group smokers daily smokers start (yrs) for Weighted n
(years) (%) smokers (%) current daily
(%) smoker
15-24 60.9 41.3 4.9 16.0 1444
25-34 79.6 61.5 14.3 18.0 1326
35-44 82.1 65.1 21.8 20.0 1266
45-54 83.8 64.9 27.5 20.0 943
55-64 88.9 68.1 44.6 20.0 645
65+ 89.1 56.5 52.8 20.0 506
Total 78.1 58.3 20.3 19.0 6130
Table 4b
Prevalence of tobacco use for female by age group
Morbidity Study (NHHS) 2001
Ever Current Ex-daily Median age at
Age smokers daily smokers start (yrs) for Weighted n
(years) (%) smokers (%) current daily
(%) smoker
15-24 3.9 1.5 0.4 14.0 1658
25-34 4.3 1.7 0.4 17.0 1728
35-44 5.7 3.1 0.6 23.9 1471
45-54 8.6 4.3 0.9 21.0 1002
55-64 7.6 5.6 1.0 19.0 629
65+ 9.5 4.3 2.5 20.0 515
Total 5.8 2.9 0.7 19.0 7003

Alcohol consumption was reported very low in the community. Only 6% among
male respondents reported as current alcohol consumer, and 22% reported as ever
consumer. Lower percentages were reported by female respondents, i.e., 1% and 2%
respectively (Tables 5a and b).

Table 5a
Prevalence of alcohol consumption for male by age group,
Morbidity Study (NHHS) 2001
Age Ever consumed Current alco- Abstainers
(years)
Weighted n
alcohol (%) hol use (%) (%)
15-24 19.6 5.3 80.4 1444
25-34 28.6 6.9 71.4 1326
35-44 27.4 6.7 72.6 1266
45-54 19.7 5.1 80.3 943
55-64 17.9 4.0 82.1 645
65+ 16.1 4.0 83.9 506
Total 22.7 5.7 77.3 6130

Table 5b
Prevalence of alcohol consumption for female by age group
Morbidity Study (NHHS) 2001

Age Ever consumed Current Abstainers


(years) alcohol alcohol use (%) Weighted n
(%) (%)
15-24 1.4 0.6 98.6 1658
25-34 1.5 0.6 98.5 1728
35-44 2.3 1.3 97.7 1471
45-54 2.3 0.6 97.7 1002
55-64 1.4 0.8 98.6 629
65+ 2.2 1 97.8 515
Total 1.8 0.8 98.2 7003
Tables 6a and 6b show mean of percentages of time (hours) of respondents
physical activity classified as inactive (see questionnaire: mean of percentages of total
physical activity falling in categories c11 or c14 or c17). Mean of percentages inactive
time is 59% for male and 64% for female. Age groups of 45-64 for male and 35-54 for
female are relatively more active than other age groups.

Table 6a
Mean of percentages inactive time for male by age groups,
Morbidity Study (NHHS) 2001

Male
Age
(years) Weighted
Mean (95% CI)
n
15-24 1444 63.5 62.3-64.7
25-34 1326 58.5 57.2-59.8
35-44 1266 57.8 56.4-59.2
45-54 943 56.2 54.6-57.8
55-64 645 55.6 53.7-57.5
65+ 506 62.2 59.8-64.6

Total 6130 59.2 58.6-59.8

Missing: male 74 (1.2%)

Table 6b
Percent distribution of mean inactive time for female by age groups,
Morbidity Study (NHHS) 2001

Female
Age
(years) Weighted
Mean (95% CI)
n
15-24 1658 66.7 65.6-67.8
25-34 1728 62.7 61.6-63.8
35-44 1471 60.3 59.1-61.5
45-54 1002 60.4 59.0-61.8
55-64 629 64.5 62.6-66.4
65+ 515 71.0 68.9-73.0

Total 7003 63.6 63.1-64.1

Missing female: 83 (1.2%)

Tables 6c and d show prevalence of respondent classified as inactive. i.e., those


respodents that more 50% of their physical activities are classified as inactive (see
questionnaire: falling in categories c11, c14 or c17). 59% for male and 70% for female
are inactive. Age groups of 45-64 for male and 35-54 for female are relatively more
active than other age groups.

Table 6c
Prevalence of inactive time for male by age group,
Morbidity Study (NHHS) 2001

Male
Age
(years) Weighted n % (95% CI)
15-24 1444 68.1 68.08 68.12
25-34 1326 58.8 58.77 58.83
35-44 1266 55.4 55.37 55.43
45-54 943 53.4 53.37 53.43
55-64 645 53.1 53.06 53.14
65+ 506 65.1 65.06 65.14
6130
Total 59.4 59.39 59.41

Missing: male 74 (1.2%)

Table 6d
Prevalence of inactive time for female by age group,
Morbidity Study (NHHS) 2001

Female
Age
(years) Weighted
% (95% CI)
n
15-24 1658 75.4 75.38 75.42
25-34 1728 69.2 69.18 69.22
35-44 1471 65.1 65.08 65.12
45-54 1002 67.4 67.37 67.43
55-64 629 70.3 70.26 70.34
65+ 515 81.1 81.06 81.14
7003
Total 70.5 70.49 70.51

Missing: Female 83 (1.2%)

Mean of weight for female (48 kg) is lower than mean of weight for male (51 kg).
Tables 7a and 7b. The highest weight for both male and female is for age group 35-44.
Mean of height for male is 158cm, 9 cm higher than for female (149 cm). Younger age
group is generally higher than older age group (Table 8a, 8b).
Table 7 a
Mean of weight for male by age group,
Morbidity Study (NHHS) 2001

Age Male
(years) Weighted n Mean (95%CI)
15-24 1444 51.5 51.1-51.9
25-34 1326 56.1 55.7-56.5
35-44 1266 57.0 56.3-57.5
45-54 943 55.9 55.3-56.5
55-64 645 52.6 51.8-53.4
65+ 506 49.5 48.7-50.3
Total 6130 51.3 51.1-51.5
Missing: male 158 (2.6%)

Table 7b
Mean of weight for female by age group,
Morbidity Study (NHHS) 2001

Age Female
(years) Weighted n Mean (95%CI)
15-24 1658 47.2 46.8-47.6
25-34 1728 50.6 50.2-51.0
35-44 1471 52.9 52.3-53.5
45-54 1002 51.5 50.9-52.1
55-64 629 48.1 47.3-48.9
65+ 515 43.8 43.0-44.6
Total 7003 47.7 47.5-47.9
Missing: female 131 (1.9%)

Table 8a
Mean of height in male by age group,
Morbidity Study (NHHS) 2001

Age Male
(years) Weighted n Mean (95%CI)
15-24 1444 160.5 160.1-160.9
25-34 1326 162.0 161.6-162.4
35-44 1266 161.3 160.9-161.7
45-54 943 160.6 160.2-161.0
55-64 645 159.0 158.3-159.5
65+ 506 157.5 156.9-158.1
Total 6130 157.6 157.4-157.8
Missing: male 158 (2.6%)
Table 8b
Mean of height in female by age group,
Morbidity Study (NHHS) 2001

Age Female
(years) Weighted n Mean (95%CI)
15-24 1658 151.4 151.2-151.6
25-34 1728 151.3 151.1-151.5
35-44 1471 151.0 150.6-151.4
45-54 1002 149.9 149.5-150.3
55-64 629 148.8 148.4-149.2
65+ 515 146.9 146.3-147.5
Total 7003 149.2 149.0-149.4
Missing: female 131 (1.9%)

Mean of body mass index (BMI) for male is 20, a little bit lower than BMI for
female (21). Proportion of male respondents with BMI 25 is 8%, and for female more
than double (17%) falls in this category. Both for male and female age group 35-54 tend
to fall in the category compared to other age groups (Tables 9a, 9b, 10a, and 10b). Only 1
% of male respondents fall in the category BMI 30, and for female respondents the
percentage is 4% (Tables 10c and 10d).

Table 9a
Mean of body mass index for male by age group,
Morbidity Study (NHHS) 2001

Male
Age
(years)
Weighted n Mean (95%CI)
15-24 1444 19.9 19.8-20.0
25-34 1326 21.4 21.2-21.6
35-44 1266 21.9 21.7-22.1
45-54 943 21.7 21.5-21.9
55-64 645 20.8 20.6-21.0
65+ 506 19.9 19.7-20.1
Total 6130 20.4 20.3-20.5
Missing: male 158 (2.6%)
Table 9b
Mean of body mass index for female by age group.
Morbidity Study (NHHS) 2001

Female
Age
(years)
Weighted n Mean (95%CI)
15-24 1658 20.5 20.4-20.6
25-34 1728 22.1 21.9-22.3
35-44 1471 23.2 22.9-23.4
45-54 1002 22.9 22.6-23.2
55-64 629 21.6 21.3-21.9
65+ 515 20.3 19.9-20.7
Total 7003 21.3 21.2-21.4
Missing: female 131 (1.9%)

Table 10a
Prevalence of BMI 25 kg/m2 for male by age group,
Morbidity Study (NHHS) 2001

Age Male
(years)
% Weighted n
15-24 2.1 1444
25-34 7.6 1326
35-44 13.1 1266
45-54 13.7 943
55-64 7.3 645
65+ 4.2 506
Total 8.1 6130
Missing: male 158 (2.6%)

Table 10b
Prevalence of BMI 25 kg/m2 for female by age group,
Morbidity Study (NHHS) 2001

Age Female
(years)
% Weighted n
15-24 5.5 1658
25-34 16.6 1728
35-44 27.4 1471
45-54 26.4 1002
55-64 18.4 629
65+ 9.2 515
Total 17.3 7003
Missing: female 131 (1.9%)
Table 10c
Prevalence of BMI 30 kg/m2 for male by age group,
Morbidity Study (NHHS) 2001

Age Male
(years)
% Weighted n
15-24 0.3 1444
25-34 0.8 1326
35-44 1.2 1266
45-54 2.3 943
55-64 0.9 645
65+ 1.2 506
Total 1.1 6130
Missing: male 158 (2.6%)

Table 10d
Prevalence of BMI 30 kg/m2 for female by age group,
Morbidity Study (NHHS) 2001

Age Female
(years)
% Weighted n
15-24 0.9 1658
25-34 3.2 1728
35-44 6.9 1471
45-54 4.9 1002
55-64 2.9 629
65+ 2.6 515
Total 3.6 7003
Missing: female 131 (1.9%)

There is no significant difference between male and female mean of waist to hip
ratio (WHR), 0.86 for male and 0.83 for female (Tables 11a and 11b). However when we
look at prevalence of central obesity (WHR >1.0 for male and WHR>0.85for female)
there is huge difference between male (2%) and female (38%). Difficulty to measure
waist and hip for female respondents by interviewer may be one reason for the difference.
Prevalence of central obesity increases by age group for female (Tables 11c and d).
Table 11a
Mean of waist to hip ratio for male by age group,
Morbidity Study (NHHS) 2001

Male
Age
(years) Weighted n Mean (95%CI)
25-34 1326 0.85 0.81-0.89
35-44 1266 0.86 0.82-0.9
45-54 943 0.87 0.83-0.91
55-64 645 0.87 0.81-0.93
65+ 506 0.86 0.8-0.92
Total 4686 0.86 0.84-0.88
Mising: male 344 (7.3%)

Table 11b
Mean of waist to hip ratio for female by age group.
Morbidity Study (NHHS) 2001

Female
Age
(years) Weighted n Mean (95%CI)
25-34 1728 0.81 0.78-0.86
35-44 1471 0.83 0.79-0.87
45-54 1002 0.84 0.78-0.9
55-64 629 0.85 0.79-0.91
65+ 515 0.85 0.79-0.91
Total 5345 0.83 0.81-0.85
Missing: female 241 (4.5%)

Table 11c
Prevalence of high risk of waist to hip ratio for male by age group.
Morbidity Study (NHHS) 2001

Age Male
(years) Weighted n % (95%CI)
25-34 1326 1.3 1.24 1.36
35-44 1266 1.5 1.44 1.56
45-54 943 4.1 3.93 4.17
55-64 645 2.5 2.52 2.68
65+ 506 1.5 1.41 1.59

Total 4686 2.1 2.07 2.13


Mising: male 344 (7.3%)
Table 11d
Prevalence of high risk of waist to hip ratio in female by age group.
Morbidity Study (NHHS) 2001

Age Female
(years) Weighted n % (95%CI)
25-34 1728 29.5 29.46 29.54
35-44 1471 35.3 35.16 35.34
45-54 1002 41.9 41.65 41.95
55-64 629 44.6 44.34 44.65
65+ 515 52.5 51.64 52.76

Total 5345 37.5 37.38 37.42

Missing: female 240 (4.5%)

Figures of blood pressure (systolic and diastolic) shown in Tables 12a and b
were based on average of two measurements. In the study mercury
sphygmomanometer was used by the doctors to measure blood pressure. The mean of
systolic blood pressure for both male and female is 125 mmHg and the mean of
diastolic blood pressure is 80 mmHg (Tables 12a and b). As expected the mean
increases by age group. Tables 12c and d show the prevalence of blood pressure
140/90 mmHg. For male respondents the prevalence is 26,5% a little bit lower than
for female respondents (29%). The prevalence increases by age groups, for male from
10% for age group 25-34 to 51% for age group 65+, and for female from 11% for age
group 25-34 to 60% for age group 65+. The prevalence in older age group is higher
for female than for male.

Table 12a
Mean of systolic and diastolic for male by age group,
Morbidity Study (NHHS) 2001

Age Weighted Systolic Diastolic


(years) n Mean (95%CI) Mean (95%CI)
25-34 1326 118.3 117.7-118.9 77.1 76.7-77.5
35-44 1266 121.8 121-122.6 79.1 78.6-79.6
45-54 943 127.0 125.7-128.1 81.3 80.6-81.9
55-64 645 134.3 132.5-136.1 83.0 82.1-83.9
65+ 506 136.9 134.9-139.1 83.8 82.8-84.8
Total 4686 125.3 124.8-125.8 80.0 79.7-80.3
Missing: 62 (1.3%)
Table 12b
Mean of systolic and diastolic for female by age group,
Morbidity Study (NHHS) 2001

Systolic Diastolic
Age Weighted n
(years) Mean (95%CI) Mean (95%CI)
25-34 1728 115.0 114.3-115.5 76.0 75.6-76.4
35-44 1471 122.1 121.3-123.1 79.4 78.8-79.9
45-54 1002 129.7 129.3-130.1 82.1 81.3-82.9
55-64 629 138.3 136.2-140.4 84.8 83.8-85.8
65+ 515 142.7 140.3-145.1 84.9 83.8-86.0
Total 5345 125.2 122.6-127.8 80.0 79.7-80.3
Missing: 47 (0.9%)

Table 12c
Prevalence of blood pressure 140/90 mmHg for male by age group,
Morbidity Study (NHHS) 2001

Male
Age
(years) Weighted
% (95%CI)
n
25-34 1326 10.4 10.35 10.45
35-44 1266 20.8 20.75 20.85
45-54 943 31.6 31.45 31.65
55-64 645 43.9 43.84 43.96
65+ 506 50.9 50.84 50.96
Total 4686 26.6 26.47 26.63
Missing: male 62 (1.3%)

Table 12d
Prevalence of blood pressure 140/90 mmHg in female by age group,
Morbidity Study (NHHS) 2001

Female
Age
(years) Weighted n % (95%CI)
25-34 1728 11.1 11.05 11.15
35-44 1471 23.4 23.45 23.55
45-54 1002 38.2 38.15 38.25
55-64 629 51.0 50.94 51.06
65+ 515 59.6 59.64 59.76
Total 5345 28.9 28.98 29.02
Missing: female 47 (0.9%)
Accutrend GC (dry chemistry) was used to examine blood glucose and total
cholesterol. The instrument used makes possible the field team observes the result
immediately. The examination was only done in Java Bali.

Tables 13a-13b show mean of capillary fasting blood glucose for male and
female in Java and Bali. The mean for male is 85mg% and for female is 82mg%.
Tables 13c depict the prevalence of fasting capillary glucose 110 mg%
(hyperglycemia) for male (9%) and for female (7%). The prevalence increase by age
group. If the criteria of 126mg% is used, the prevalence for male is 4% and for
female is 3% (Table 13d).

Table 13a
Mean of capillary fasting blood glucose (mg%) for male by age group,
Morbidity Study, Java-Bali (NHHS) 2001

Male
Age
(years) Weighted n Mean (95%CI)
25-34 572 81.9 79.9-83.9
35-44 522 83.9 81.1-86.7
45-54 372 86.2 83.0-89.4
55-64 252 84.8 82.0-87.6
65+ 177 91.4 85.0-97.8
Total 1895 84.9 83.5-86.3
Missing: male 365 (11.7%)

Table 13b
Mean of fasting blood glucose (mg%) for female by age group,
Morbidity Study, Java-Bali (NHHS) 2001

Female
Age
(years) Weighted n Mean (95%CI)
25-34 739 75.8 74.2-77.4
35-44 597 81.6 79.2-84.0
45-54 417 86.3 82.7-89.9
55-64 244 86.8 82.6-91.0
65+ 189 83.7 79.7-87.7
Total 2186 81.6 80.3-82.9
Missing: female 432 (11.9%)
Table 13c
Prevalence of capillary fasting blood glucose 110 mg% for male and female by
age group Morbidity Study, Java-Bali (NHHS) 2001

Age Male Female


(years) Weighted n % Weighted n %
25-34 572 7.0 739 3.6
35-44 522 8.7 597 6.2
45-54 372 9.4 417 9.5
55-64 252 9.9 244 11.5
65+ 177 10.9 189 8.4
Total 1895 8.9 2186 6.9
Missing: male 365 (11.7%), female 432 (11.9%)

Table 13d
Prevalence of capillary fasting blood glucose 126mg% by sex and age groups
Morbidity Study, Java-Bali (NHHS) 2001

Age Male Female


(years) 126mg% N (weight) 126mg% N (weight)
(%) (%)
25-34 2.8 572 0.8 739
35-44 3.9 522 3.6 597
45-54 4.4 372 5.1 417
55-64 4.8 252 5.3 244
65+ 7.3 177 3.9 189
Total 4.2 1895 3.3 2186
Missing: male 365 (11.7%); female 432 (11.9%)

Tables 14a and b show mean of total cholesterol for male and female respondents in
Java Bali. The mean for male is 171mg% and mean for female is 173mg%.
Prevalence of total cholesterol > 200 mg% for male and female are 6% and 8%
respectively (Tables 14c). Prevalence of hypercholesterolemia using cut off point total
cholesterol 193.5 mg/dl is 9% for male and 11% for female (Table 14d).
Table 14a
Mean of total cholesterol (mg%) for male by age group
Morbidity Study, Java-Bali (NHHS) 2001

Age Male
(years)
Weighted n Mean (95%CI)
25-34 572 165.9 164.1-167.7
35-44 522 171.1 168.9-173.3
45-54 372 175.5 172.7-178.3
55-64 252 173.5 170.5-176.5
65+ 177 168.9 165.9-171.9
Total 1895 170.8 169.6-172.0
Missing: male 390 (12.5%)

Table 14b
Mean of total cholesterol (mg%) for female by age group
Morbidity Study, Java-Bali (NHHS) 2001

Age Female
(years)
Weighted n Mean (95%CI)
25-34 739 165.2 163.8-166.6
35-44 597 172.6 170.8-174.4
45-54 417 178.5 175.7-181.3
55-64 244 182.6 179.0-186.2
65+ 189 175.8 172.0-179.6
Total 2186 172.8 171.6-174.0
Missing: female 432 (11.9%)

Table 14c
Prevalence of total cholesterol > 200 mg% for male and female by age group
Morbidity Study, Java-Bali (NHHS) 2001

Age Male Female


(years) Weighted n % Weighted n %
25-34 572 3.9 739 3.4
35-44 522 7.4 597 8.1
45-54 372 6.1 417 11.2
55-64 252 6.6 244 14.8
65+ 177 5.2 189 7.2
Total 1895 5.8 2186 8.0
Missing: male 390 (12.5%), female 432 (11.9%)
Table 14d
Prevalence of total cholesterol 193.5 mg/dl by sex and age groups
Morbidity Study, Java-Bali (NHHS) 2001

Age Male Female


(years) 193.5 mg/ dl Weighted n 193.5 mg/ dl Weighted n
(%) (%)
25-34 6.4 572 5.4 739
35-44 11.3 522 11.3 597
45-54 10.4 372 15.3 417
55-64 9.0 252 18.8 244
65+ 8.9 177 10.1 189
Total 9.2 1895 11.1 2186
Missing: male 391 (12.5%); female 432 (11.9%)

Obesity (BMI 30kg/m2)

5
Percent

Male
4
Female
3

0
15-24 25-35 35-44 45-54 55-64 65+
Age range

Definition: BMI 30 kg/m2


Survey Population: National, both urban dan rural populations
Source: Ministry of Health; Indonesia Health Survey (Surkesnas)2001
Body Mass Index (mean)
24 Male
Female
23

Mean (kg/m2) 22

21

20

19

18
15-24 25-34 35-44 45-54 55-64 65+
Age range

Definition: kg/m2
Survey Population: National, both urban dan rural populations
Source: Ministry of Health; Indonesia Health Survey (Surkesnas)2001

Raised Blood Pressure (140/90 mmHg)


Male
Female
70

60

50
Percent

40

30

20

10

0
25-34 35-44 45-54 55-64 65+
Age range

Definition: SBP 140 mmHg /DBP>90 mmHg


Survey Population: National, both urban dan rural populations
Source: Ministry of Health; Indonesia Health Survey (Surkesnas)2001
Systolic Blood Pressure (mean)
160 Male
140 Female

120
Mean (mmHg)
100

80

60

40

20

0
25-34 35-44 45-54 55-64 65+
Age range

Definition: mmHg
Survey Population: National, both urban dan rural populations
Source: Ministry of Health; Indonesia Health Survey (Surkesnas)2001

S-ar putea să vă placă și